探讨经右侧锁骨下动脉穿刺入路行介入治疗的安全性。

回顾性收集临沧市人民医院介入科自2014年7月至2021年5月经右侧锁骨下动脉入路行介入治疗的106例患者，男14例，女92例，平均年龄（40.36 ± 13.06）岁，其中行妇科介入治疗66例，下肢动脉血栓形成置管溶栓30例，下肢静脉血栓置管溶栓6例，肝癌介入治疗3例，其他介入治疗1例。

105例患者成功穿刺置管，穿刺成功率99.05%，1例穿刺失败更换左侧股动脉入路成功行右下肢动脉栓塞置管溶栓术。所有病例无危及生命的严重并发症发生，其中1例患者穿刺后出现胸壁血肿，后经加压包扎好转出院。

经右侧锁骨下动脉穿刺入路行介入治疗安全，便于术者操作，术后患者无需卧床，舒适性高，护理方便，尤其适用于需要置管持续溶栓和持续动脉灌注化疗的患者。

To investigate the safety of interventional therapy via right subclavian artery approach.

A total of 106 patients (14 males and 92 females) with an average age of 40.36 ± 13.06 years, who received interventional therapy through right subclavian artery approach in our center from July 2014 to May 2021, were retrospectively collected, including 66 cases of gynecological interventional therapy, 6 cases of thrombolysis with lower limb venous thrombosis and 30 cases of thrombolysis with lower limb arterial embolization. 3 cases of hepatocellular carcinoma were treated by interventional therapy,1 case was treated by other interventional therapy.

105 patients were successfully catheterized, the success rate of catheterization was 99.05%, and 1 failure patient was successfully catheterized for right lower limb artery embolization by replacing left femoral artery approach. No serious life-threatening complications occurred in all cases, and 1 patient diagnosed chest wall hematoma after puncture, which was healing after compression and discharged.

Interventional therapy via right subclavian artery is safe and convenient procedure, postoperative patients do not need to lie in bed, with high comfort and convenient nursing, especially suitable for the patients who need continuous thrombolysis and continuous arterial infusion chemotherapy.